SILVERMAN LOU 4
4 · Oncocyte Corp · Filed Jun 27, 2023
Insider Transaction Report
Form 4
SILVERMAN LOU
Director
Transactions
- Award
Option to Purchase Common Stock
2023-06-23+112,500→ 112,500 totalExercise: $0.20Exp: 2033-06-23→ Common Stock (112,500 underlying) - Award
Common Stock, no par value
2023-06-23+25,000→ 31,270 total
Footnotes (2)
- [F1]The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.
- [F2]Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.